Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine Followed by Iodine I 131 Tositumomab for Untreated Low-grade and Follicular NHL
NCT00933335Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 1998
- Primary completion
- Dec 2009
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of iodine i 131 tositumomab in follicular lymphoma (FL), non-Hodgkin lymphoma (NHL), sponsored by GSK. Started Aug 1998; status: completed.
02
Drugs
iodine i 131 tositumomab
03
Conditions
follicular lymphoma (FL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00933335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00933335.